Pressbee - PR Newswire :
Watch the post from Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results, Now to the details :
CORAL GABLES, Fla., Aug. 11, 2022 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD) ("Relmada," the "Company," "we," "us, "our"), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary...
For more, read the news from the source
Relmada Therapeutics Provides Corporate Update and Reports Second Quar
This was the summery for Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results We hope that we have succeeded by sharing the full details of this topic.
PR Newswire Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results CORAL GABLES, Fla., Aug. 11, 2022 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD) ("Relmada," the "Company," "we," "us, "our"), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary...
Please note that the original topic has been published and is available on PR Newswire the editing team at PressBee have verified it and it may have been partially modified or quoted from it. You can read and follow this news or topic from its main source.
